Redox key facts
as of Oct 2026- Developer of a composable healthcare program interface technology designed to eradicate technical barriers in healthcare systems.
- Redox is valued at approximately $310.0M as of Oct 2026 (last reported valuation).
- It has raised $95.2M; the latest was Later Stage VC ($20K) in May 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, MedTech Innovator, Flybridge (New York), Texas Medical Center — 22 tracked in total.
- Status: Privately Held (backing).
Redox's last reported valuation, Feb 2021. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch Redox: the Monday email on marks, rounds and moves
Redox funding rounds
No funding rounds for Redox are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Redox
22+Redox valuation
Redox's last reported valuation was $310 million in Feb 2021. No priced round, secondary trade or fund mark has surfaced since.
Redox investors
22 investors are on record for Redox, including Plug and Play Tech Center, MassChallenge, MedTech Innovator and Flybridge (New York). By type, the record holds 5 venture capital firms and 2 growth equity firms.
About Redox
Developer of a composable healthcare program interface technology designed to eradicate technical barriers in healthcare systems. The company offers a platform that standardizes data and maintains integrations to remove distractions to help focus on what's important, enabling vendors and providers to secure and share reliable healthcare data.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2014
- Employees
- 224
- Website
- redoxengine.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.